213 related articles for article (PubMed ID: 34539647)
1. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.
Zhang J; Tao J; Gao RN; Wei ZY; He YS; Ren CY; Li QC; Liu YS; Wang KW; Yang G; Qian C; Chen JH
Front Immunol; 2021; 12():715559. PubMed ID: 34539647
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota modulate T cell trafficking into human colorectal cancer.
Cremonesi E; Governa V; Garzon JFG; Mele V; Amicarella F; Muraro MG; Trella E; Galati-Fournier V; Oertli D; Däster SR; Droeser RA; Weixler B; Bolli M; Rosso R; Nitsche U; Khanna N; Egli A; Keck S; Slotta-Huspenina J; Terracciano LM; Zajac P; Spagnoli GC; Eppenberger-Castori S; Janssen KP; Borsig L; Iezzi G
Gut; 2018 Nov; 67(11):1984-1994. PubMed ID: 29437871
[TBL] [Abstract][Full Text] [Related]
3. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
4. Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.
Zhu G; Su H; Johnson CH; Khan SA; Kluger H; Lu L
Eur J Cancer; 2021 Jul; 151():25-34. PubMed ID: 33962358
[TBL] [Abstract][Full Text] [Related]
5. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
6. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
Zumwalt TJ; Arnold M; Goel A; Boland CR
Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
8. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
9. NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.
Muthuswamy R; Berk E; Junecko BF; Zeh HJ; Zureikat AH; Normolle D; Luong TM; Reinhart TA; Bartlett DL; Kalinski P
Cancer Res; 2012 Aug; 72(15):3735-43. PubMed ID: 22593190
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
[TBL] [Abstract][Full Text] [Related]
11. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
[TBL] [Abstract][Full Text] [Related]
13. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.
Löfroos AB; Kadivar M; Resic Lindehammer S; Marsal J
Eur J Med Res; 2017 Oct; 22(1):40. PubMed ID: 29020986
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
16. Metagenomics analysis of cultured mucosal bacteria from colorectal cancer and adjacent normal mucosal tissues.
Zhu Y; Ma L; Wei W; Li X; Chang Y; Pan Z; Gao H; Yang R; Bi Y; Ding L
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35467501
[No Abstract] [Full Text] [Related]
17. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
Allali I; Delgado S; Marron PI; Astudillo A; Yeh JJ; Ghazal H; Amzazi S; Keku T; Azcarate-Peril MA
Gut Microbes; 2015; 6(3):161-72. PubMed ID: 25875428
[TBL] [Abstract][Full Text] [Related]
18. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
19. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.
Yu AI; Zhao L; Eaton KA; Ho S; Chen J; Poe S; Becker J; Gonzalez A; McKinstry D; Hasso M; Mendoza-Castrejon J; Whitfield J; Koumpouras C; Schloss PD; Martens EC; Chen GY
Cell Rep; 2020 Apr; 31(1):107471. PubMed ID: 32268087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
